$CTNM
Contineum Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$12.95
▼-1.97%-$0.260
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateContineum Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CTNM up today? It is at $12.95 (+0.00%), and our scanner flagged it 50 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CTNM spikes, and full due diligence on CTNM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CTNM 50 times in the last 30 days. Create a free account to track $CTNM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CTNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $41K at $16.46 | Sep 8, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Sep 8, 26 |
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $40K at $16.01 | Aug 3, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Aug 3, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -25 | sold <0.1% | 135K | $400 at $16.00 | Jul 9, 26 |
Lorrain Daniel S. Officer | Other | 25 | added <0.1% | 135K | $25 at $1.01 | Jul 9, 26 |
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $40K at $16.00 | Jul 8, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Jul 8, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -1K | sold 0.7% | 135K | $16K at $16.00 | Jul 8, 26 |
Lorrain Daniel S. Officer | Other | 1K | added 0.8% | 136K | $1K at $1.01 | Jul 8, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -8K 0.02% of company | sold 5.8% | 135K | $131K at $15.67 | Jul 1, 26 |
Lorrain Daniel S. Officer | Other | 4K 0.01% of company | added 3.0% | 144K | $4K at $1.01 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CTNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CTNM last traded at $12.95, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is next expected to report earnings on Thursday, October 29, 2026, about 41 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CTNM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CTNM 50 times in the last 30 days.
CTNM (Contineum Therapeutics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $518M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CTNM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CTNM discussion
Sign in to ask a question or join the discussion.